Mission Statement

Our mission is to broaden the medical and personal skills of our trainees to enable them to effectively practice medicine in radiation oncology. Our faculty offers a mentor-apprentice educational model in the radiation oncology clinic within The James Cancer Hospital. We provide 3 preparatory courses: Clinical Radiation Oncology, Radiation Physics, and Radiation Biology. The educational component of training is supplemented with weekly chart rounds, cancer center grand rounds, monthly journal club, resident-led case conferences, and morbidity and mortality conferences. The cancer center holds over 14 disease-specific tumor boards and multidisciplinary conferences. Our residents participate in annual mock oral boards and exam reviews to hone their information presentation skills.

OSU Radiation Oncology provides a complete spectrum of radiation therapy modalities, so all technical skills can be learned in an optimal setting. This includes; gamma knife stereotactic radiosurgery, linac-based stereotactic radiosurgery, ample gynecologic and genitourinary brachytherapy, a varied and robust pediatric experience, and stereotactic body radiation therapy. Our $1.1 billion dollar cancer hospital, constructed in 2014, provides an ideal environment to acquire and hone your skills. The Arthur G. James Cancer Hospital and Solove Research Institute is a NCI-designated Comprehensive Cancer Center where medical and surgical oncologists are in close proximity to radiation oncology colleagues; this provides the ideal environment for clinical, education, and research interactions. We emphasize the need for radiation oncologists to function as partner in a multidisciplinary cancer medicine team.

Contact Us

For more Information regarding our Residency Programs:

Education Manager
Meg Decker

The James Cancer Hospital
460 W. 10th Ave
Second Floor
Columbus, Ohio 43210

Raju Raval, MD, DPhil

Residency Program Director

Raju Raval


Dr. Raval focuses on radiation oncology with a specialization in treating patients with genitourinary cancers and primary central nervous system lymphoma.

Learn More